The economics of stone disease.
World J Urol
; 35(9): 1321-1329, 2017 Sep.
Article
en En
| MEDLINE
| ID: mdl-28108799
ABSTRACT
The rising prevalence of kidney stone disease is associated with significant costs to healthcare systems worldwide. This is in part due to direct procedural and medical management costs, as well as indirect costs to health systems, patients, and families. A number of manuscripts evaulating the economics of stone disease have been published since the 2008s International Consultation on Stone Disease. These highlight costs associated with stone disease, including acute management, surgical management, and medical management. This work hopes to highlight optimization in care by reducing inefficient treatments and maximizing cost-efficient preventative strategies.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Nefrostomía Percutánea
/
Litotricia
/
Cálculos Ureterales
/
Costos de la Atención en Salud
/
Costo de Enfermedad
/
Nefrolitiasis
/
Tratamiento Conservador
/
Hospitalización
Tipo de estudio:
Health_economic_evaluation
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
World J Urol
Año:
2017
Tipo del documento:
Article
País de afiliación:
Estados Unidos